Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1988-8-11
pubmed:abstractText
We evaluated the use of horse blood agar containing 0.0005% pyridoxal hydrochloride (HBAP) mainly for use as a primary plating medium for blood cultures, other sterile fluids, wounds, and abscesses in order to facilitate the isolation of nutritionally deficient streptococci (NDS). Our results showed that the addition of pyridoxal hydrochloride (pxl) permitted good growth of NDS within 24 h and did not inhibit or significantly alter the colony morphology of 34 different species of microorganisms and 296 isolates of beta hemolytic streptococci presumptively identified as Group A streptococci. The use of pxl-supplemented blood agar such as HBAP is recommended for primary plating as well as subculturing of blood cultures, and may also increase recovery of NDS from wounds and abscesses.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0732-8893
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
119-21
pubmed:dateRevised
2000-12-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Usefulness of pyridoxal-containing blood agar as a primary plating medium to enhance recovery of nutritionally deficient streptococci.
pubmed:affiliation
Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892.
pubmed:publicationType
Journal Article